CLINICAL_TRIALS
trial_result
· 2017-05-30
Clinical Trial Update: Efficacy and Safety of Naldemedine in Treating Opioid-induced Constipation [Phase 3]
Summary
A Phase 3 clinical trial update reports on the efficacy and safety of naldemedine for treating opioid-induced constipation.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Shionogi | Conditions: Opioid-induced Constipation | Phase 3 | Status: COMPLETED | Results posted: 2017-05-30